Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder

This study has been withdrawn prior to enrollment.
(Withdrawal of the administrative reason)
Sponsor:
Information provided by (Responsible Party):
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT02006199
First received: December 4, 2013
Last updated: October 12, 2016
Last verified: December 2013
  Purpose
Hypothesis of this study is that mindfulness meditation would decrease the severity of obsessive-compulsive symptoms.

Condition Intervention
Obsessive-compulsive Disorder
Behavioral: mindfulness meditation

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of Mindfulness Based Treatment for Obsessive-compulsive Disorder

Resource links provided by NLM:


Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • Yale-Brown Obsessive compulsive scores [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Neurocognitive profile (emotion-memory task) [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Other Outcome Measures:
  • HAM-D [ Time Frame: 8 weeks ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: October 2013
Estimated Study Completion Date: July 2014
Estimated Primary Completion Date: July 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: relaxation with psychoeducation
after 8 weeks of relaxation with psychoeducation. subject take part in 8 weeks of the mindfulness meditation program
Behavioral: mindfulness meditation
8 weeks of mindfulness meditation specified for OCD patient
Experimental: meditation
8 weeks of mindfulness meditation
Behavioral: mindfulness meditation
8 weeks of mindfulness meditation specified for OCD patient

Detailed Description:
Before and after 8 weeks of mindfulness program, We will measure Y-BOCS scores in OCD patients. As a control program, relaxation and psychoeducation will provided to OCD patients.
  Eligibility

Ages Eligible for Study:   17 Years to 55 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • obsessive-compulsive disorder
  • age 17-55

Exclusion Criteria:

  • currently undergoing Cognitive Behavioral Therapy, psychotherapy
  • other medical disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02006199

Locations
Korea, Republic of
Seoul National University Hospital
Seoul, Korea, Republic of, 110-744
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jun Soo Kwon, MD phD Seoul National University College of Medicine
  More Information

Responsible Party: Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT02006199     History of Changes
Other Study ID Numbers: 1306-076-498 
Study First Received: December 4, 2013
Last Updated: October 12, 2016
Health Authority: Korea: Institutional Review Board
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by Seoul National University Hospital:
obsessive-compulsive disorder
mindfulness
meditation

Additional relevant MeSH terms:
Disease
Compulsive Personality Disorder
Obsessive-Compulsive Disorder
Compulsive Behavior
Pathologic Processes
Personality Disorders
Mental Disorders
Anxiety Disorders
Impulsive Behavior

ClinicalTrials.gov processed this record on December 07, 2016